Navigation Links
BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment
Date:1/13/2014

JERUSALEM, Jan. 13, 2014 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has filed the necessary regulatory submissions to commence a Phase 1 trial for BL-8040, a novel treatment for the mobilization of stem cells from the bone marrow to the peripheral blood circulation. The regulatory submissions were filed with the Hadassah Medical Center Institutional Review Board (IRB), and the study is expected to commence during the second quarter of 2014.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769)

The Phase 1 study will be divided into two parts. Part 1 is a randomized, double-blind, placebo-controlled dose escalation study exploring the safety and tolerability of escalating repeated doses of BL-8040 in healthy volunteers. Secondary objectives include assessment of the efficacy of BL-8040 in mobilizing stem cells as a stand-alone therapy, as well as monitoring the pharmacokinetic profile of the drug. This part will be performed in up to 4 cohorts, with 8 healthy volunteers in each cohort. Part 1 of the study will serve to select the optimal safe and efficacious dose of BL-8040 to be used as a stand-alone therapy in Part 2 of the study.

Part 2 is an open-label study designed to assess BL-8040's stem cell mobilization capacity, as well as the yield of cells collected by leukapheresis. Secondary endpoints of the study include evaluation of the viability and biological activity of cells mobilized by BL-8040 and collected by leukapheresis. This part will be performed in a single cohort of 8 healthy volunteers who will receive the selected dose regimen of BL-8040 based on the data from Part 1.

"Increas
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment
2. BioLineRx to Present at Biotech Showcase Conference in San Francisco
3. BioLineRx Enters Clinic with Novel Treatment for Celiac Disease
4. BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment
5. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
6. BioLineRx Announces New Positive Results in Phase 2a trial for Orally Available Inflammatory Bowel Disease Treatment
7. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
8. BioLineRx Reports Third Quarter 2013 Financial Results
9. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
10. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
11. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...   Physicians Rx Pharmacy ("PRxP") today announced ... organization as President and Chief Executive Officer.  ... Chief Executive Officer for Soleo Health Specialty Infusion Services, ... Rx Pharmacy, be responsible for leading the rapidly-growing 340B ... to bring Gaston on as the President and CEO ...
(Date:9/2/2015)... 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ... Latin America (London, UK - November 16-18, 2015)" conference to their ... Latin America including Columbia, Peru , ... , Uruguay , Paraguay , ... Central America , Chile This ...
(Date:9/2/2015)... , Sept. 2, 2015 Research ... addition of the "Medical Device Studies: Clinical ... conference to their offering. This ... are involved in gathering clinical evidence required for ... is required for all medical devices and the ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... March 15, 2011 AstraZeneca today announced enrolment of ... for NKTR-118, an oral peripherally-acting opioid antagonist being investigated ... III clinical programme is designed to investigate the safety ... opioid induced constipation, a common side effect of prescription ...
... March 15, 2011 Southern Home Medical Equipment, ... services, healthcare professionals and equipment to medical institutions, ... growth.  After two consecutive profitable years, zero long-term ... to pursue additional revenues and growth opportunities. ...
Cached Medicine Technology:AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation 2AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation 3Southern Home Medical Equipment Engages Northern Virginia Based Waterford Holdings Group to Evaluate and Consider Acquisition Candidates in the Mid-Atlantic Area 2
(Date:9/2/2015)... ... 2015 , ... Based in Beverly Hills, Luxury Line Auto Rental explains that ... on which of the latest and greatest vehicles their customers want to drive the ... this goal: a 2015 Rolls Royce Wraith rental in Los Angeles is ...
(Date:9/2/2015)... ... September 02, 2015 , ... Specifically, VOI ... news recently following a decision by the Centers for Medicare & Medicaid Services ... average approximately $71,000 or roughly 40% of its headline-grabbing $178,000 price tag. ...
(Date:9/2/2015)... , ... September 02, 2015 ... ... of high-quality patient safety and efficacy endpoint data collection, cloud analytics and ... Insights Educational Series. The series enables pharmaceutical researchers to participate in interactive ...
(Date:9/2/2015)... ... September 02, 2015 , ... Splashtop Inc., ... addition to its screen mirroring and extending product line -- Splashtop Wired ... operates in local WIFI setting, the new Splashtop Wired XDisplay delivers enhanced performance ...
(Date:9/2/2015)... Pune (PRWEB) , ... September 02, 2015 , ... The ... USD 10.3 billion in 2015, at a CAGR of 5.2%. The global medical waste ... and geography. The treatment and disposal segment is expected to register the highest growth ...
Breaking Medicine News(10 mins):Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 2Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 3Health News:Analysis Shows Amgen’s Leukemia Drug, Blincyto, Will Cost 60% Less than Highly Publicized $178,000 Price Tag 4Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5
... Radian Guaranty Inc., the,primary mortgage insurance subsidiary of ... that mortgages originated under "stated income" and "stated,asset" ... insurance. In a,message to clients this week, Radian ... verify assets and income are appropriate,with a disciplined ...
... from UCLA used a high resolution technique to examine the ... embryonic stem cell lines and found that while both lines ... of certain genes that could control such things as individual ... the genome, which contains all the genes on 46 chromosomes, ...
... Ga., March 27 Immucor, Inc.,(Nasdaq: BLUD ), ... blood transfusion industry, today announced that it expects,to release ... after the,close of regular trading hours, and then host ... AM (EDT) to review the results. Investors,are invited to ...
... infections , , THURSDAY, March 27 (HealthDay News) -- ... been determined by biologists at Purdue University in Indiana. ... infects more than 50 million people a year and ... is prevalent in Southeast Asia, Central America and South ...
... Major Studies and Models on, Long-Term Care ... ANNAPOLIS, Md., March 27 The first,comprehensive review ... America,s elderly is now available, the National Investment ... announced today. This major,undertaking, conducted by RTI International ...
... completes fellowship at Stanford University and returns to,Vietnam ... March 27 Three leading California,eye surgeons will ... participate in a,sight-saving mission April 14 - 18 ... state-of-the-art medical and teaching facility housed inside a ...
Cached Medicine News:Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 2Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 3Health News:Radian Guaranty Inc. Eliminates 'Stated Income' and 'Stated Asset' Programs 4Health News:UCLA researchers examine human embryonic stem cell genome 2Health News:UCLA researchers examine human embryonic stem cell genome 3Health News:Immucor Schedules Third Quarter Earnings Release and Conference Call 2Health News:Biologists Discover How Dengue Virus Matures 2Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 2Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 3Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 4Health News:Insights on Paying for Boomers' Care Needs in 20-40 Years Helped by New Report 5Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 2Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 3Health News:California Eye Surgeons Journey to Vietnam to Perform Sight-Saving Surgery 4
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... The NOW Hepatitis B test is a ... diagnosis of a Hepatitis B infection. This simple, ... for accurate treatment and improved patient outcomes. , ... is an in vitro immunodiagnostic test for the ...
... is the newest technology available in acrylic ... combines exceptional material and design properties to ... Biostability , Unique foldable hydrophobic acrylic material ... be biostable , High index of ...
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Medicine Products: